Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03710590 · ClinicalTrials.gov registry record · NA
Effects of Electronic Cigarette Settings and Liquid Concentrations in Cigarette Smokers and Electronic Cigarette Users
A NA study of Electronic Cigarettes, sponsored by Virginia Commonwealth University.
- Completed
- Registry status
- NA
- Development phase
- 45
- Enrollment target
- 1
- Study location
NCT03710590: Completed NA study of Electronic Cigarettes, sponsored by Virginia Commonwealth University.
NCT03710590 is a NA study of Electronic Cigarettes that has completed, run by Virginia Commonwealth University. The registered enrollment target is 45 participants, above the 35-participant average among 3 other Electronic Cigarettes trials with a reported enrollment target (29% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03710590, a NA study of Electronic Cigarettes, has completed, sponsored by Virginia Commonwealth University.
- COMPLETED
- Registry status
- NA
- Development phase
- 45 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research study is to find out how different types of electronic cigarettes (ECIG) settings, combined with e-liquids of differing nicotine concentrations, affect blood nicotine levels, use behavior (how users puff), and how users feel.
Primary Outcome
Change in plasma nicotine level.
Conditions Studied
Interventions
- OTHER ECIG Lab Session 15 watts, 10 mg nicotine
- OTHER ECIG Lab Session 15 watts, 15 mg nicotine
- OTHER ECIG Lab Session 15 watts, 30 mg nicotine
- OTHER ECIG Lab Session 30 watts, 10 mg nicotine
- OTHER ECIG Lab Session 30 watts, 15 mg nicotine
Study Locations (1)
Virginia
- Clinical Behavioral Pharmacolgy Laboratory - Richmond
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2019-01-15 |
| Est. Completion | 2020-03-09 |
| Phase | NA |
What the finished NCT03710590 record still lists
NCT03710590 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 45 participants, a relatively small participant target, above the 35-participant average among 3 other Electronic Cigarettes trials with a reported enrollment target (29% higher).
The record links to 1 condition, with Electronic Cigarettes appearing as the primary indexed condition, and to 5 interventions - of which ECIG Lab Session 15 watts, 10 mg nicotine is the first listed.
NCT03710590 reports a single indexed study location in Virginia.
Frequently Asked Questions
What is clinical trial NCT03710590 about?
NCT03710590 is a clinical study titled "Effects of Electronic Cigarette Settings and Liquid Concentrations in Cigarette Smokers and Electronic Cigarette Users". The purpose of this research study is to find out how different types of electronic cigarettes (ECIG) settings, combined with e-liquids of differing nicotine concentrations, affect blood nicotine levels, use behavior (how users puff), and how users feel.
What is the current status of trial NCT03710590?
This trial is currently completed. It is a NA study. The enrollment target is 45 participants. The study started on 2019-01-15. Estimated completion is 2020-03-09.
What conditions does trial NCT03710590 study?
This clinical trial studies the following conditions: Electronic Cigarettes.
What interventions are being tested in trial NCT03710590?
The interventions under investigation include: ECIG Lab Session 15 watts, 10 mg nicotine (OTHER), ECIG Lab Session 15 watts, 15 mg nicotine (OTHER), ECIG Lab Session 15 watts, 30 mg nicotine (OTHER), ECIG Lab Session 30 watts, 10 mg nicotine (OTHER), ECIG Lab Session 30 watts, 15 mg nicotine (OTHER).
Who is sponsoring clinical trial NCT03710590?
This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03710590 being conducted?
This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Electronic Cigarettes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00804154 · 45 participants · Phase 1
Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer
- NCT01851694 · 45 participants · NA
Beta-cell Response to Incretin Hormones in Cystic Fibrosis
- NCT02896335 · 45 participants · Phase 2
Palbociclib and Pembrolizumab In Central Nervous System Metastases
- NCT03454035 · 45 participants · Phase 1
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI